Evidence map›Paper›PMID 41445605›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies

Joseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, Reza Arsanjani, Isaac E Prah, Nicholas J Boddicker, James R Cerhan, Melissa C Larson, Raphael Mwangi, Thomas M Habermann and 11 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Joseph S ReddyQuantitative Health Sciences, Mayo Clinic Florida, Jacksonville, FL, USA.ORCID 0000-0002-1783-4453
Milagros PereyraCardiovascular Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.ORCID 0000-0003-4695-8436
Mohammed Tiseer AbbasCardiovascular Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.ORCID 0009-0004-7212-435X
Reza ArsanjaniCardiovascular Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.ORCID 0000-0001-7081-4286
Isaac E PrahCancer Biology, Mayo Clinic Florida, Jacksonville, FL, USA.
Nicholas J BoddickerDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.
James R CerhanDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.
Melissa C LarsonDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
Raphael MwangiDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
Thomas M HabermannDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Hector R VillarragaDepartment of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0002-3675-6948
Robert A VierkantQuantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-6242-5221
Tony C LuehrsDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0009-0009-8446-5553
Hugues SicotteQuantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Jan B EganCenter for Individualized Medicine, Mayo Clinic, Scottsdale, AZ, USA.ORCID 0000-0002-2155-3099
Konstantinos N LazaridisCenter for Individualized Medicine, Mayo Clinic, Scottsdale, AZ, USA.ORCID 0000-0002-0437-681X
Maryam MoossaviBiochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Xiaolei XuBiochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4928-3422
Pooja P AdvaniHematology and Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Chadi AyoubCardiovascular Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.ORCID 0000-0001-5877-7478
Nadine NortonCancer Biology, Mayo Clinic Florida, Jacksonville, FL, USA.ORCID 0000-0002-3848-4288

Funding

The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI HOUTMAN, JON C.D. · 2002 to 2021
$45.7M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
Individualized medicine to predict and prevent chemotherapy-related heart failureR01HL169268 · NHLBI · MAYO CLINIC JACKSONVILLE · PI NORTON, NADINE · 2023 to 2025
$1.9M
NCI NIH HHS P50 CA097274NCI NIH HHS U01 CA195568NHLBI NIH HHS R01 HL169268
6 · The paper itself

Abstract

Background: Anthracyclines are a widely used and effective class of chemotherapy. However, a major limitation for their use is cardiotoxicity, manifesting as systolic dysfunction, congestive heart failure (HF) and arrhythmias. Objective: Identify genes and genetic risk variants for doxorubicin-induced arrhythmia. Methods: We performed genome-wide association studies (GWAS) and meta-analysis across two independent non-overlapping, genetically homogenous datasets from the Molecular Epidemiology Resource (MER, cases N=77, controls, N=1,184) and Tapestry, (cases N=13, controls, N=172). Doxorubicin-related arrhythmia was the primary cardiac outcome followed by investigation of a broader phenotype of cardiac events. Effects of doxorubicin on top associated genes were assessed by qPCR on RNA extracted from human cardiomyocytes following treatment with doxorubicin and by echocardiography in a zebrafish model of doxorubicin-induced cardiomyopathy. Results: In the meta-analysis, Conclusions: Genetic variants at

Indexed as

adriamycinAnthracyclinecardiomyopathycardiotoxicitychemotherapy-related heart failureheart failuremetalloproteinasepotassium channel

Identifiers

PMID41445605
PMCPMC12724149

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.